# Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis

> **NCT00843856** · PHASE4 · COMPLETED · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 40 (actual)

## Conditions studied

- Glomerulonephritis, Membranous

## Interventions

- **DRUG:** tacrolimus
- **DRUG:** tacrolimus and mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00843856
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-03
- **Primary completion:** 2018-03
- **Final completion:** 2018-09-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843856, "Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00843856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*